| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |